Peter McCullough and Joe Rogan Revisit COVID-19: Claims and Evidence

The physician and podcast host discuss pandemic policies, vaccines and treatments. Several of their central medical claims conflict with published evidence.

PMPeter McCulloughGuest · Physician
Channel
PowerfulJRE
Published
Nov 4, 2026
Video
2:36:09
Read
12 min
Original
English
Open on YouTube
Scroll to read and the video shrinks to the bottom-right corner. Captions follow your reading language.
Reading languageAvailable in 2 languages
You're reading the original English.
SUMMARY

In 30 seconds

Peter McCullough returns to Joe Rogan’s podcast to criticize the pandemic response and promote his views on COVID-19 treatment and vaccination. Their discussion ranges from public trust and professional consequences to vaccine safety and hospital care. Key assertions—including claims about ivermectin, miscarriage and cancer—require context from clinical research and public-health evidence.

  1. 1A dispute over COVID treatmentsThe speakers promote ivermectin and hydroxychloroquine; WHO guidance does not support their broad use for COVID-19.
  2. 2The history of vaccination is contestedMcCullough emphasizes sanitation, while large-scale research documents the impact of immunization.
  3. 3Pregnancy claims conflict with population studiesStudies have not found a greater risk of miscarriage after COVID-19 vaccination.
  4. 4Anecdotes do not establish the cause of cardiac eventsRare myocarditis is recognized after some vaccines, but individual cases require medical investigation.
  5. 5Cancer claims lack evidenceThe National Cancer Institute says there is no evidence COVID-19 vaccines cause cancer.

Takeaways

  1. The speakers criticize pandemic communications and say professional disagreement was suppressed.
  2. WHO recommends against ivermectin for non-severe COVID-19 and restricts its use in severe cases to clinical trials.
  3. Large studies have not found that COVID-19 vaccination increases miscarriage risk.
  4. Rare serious vaccine reactions exist, but individual events after vaccination do not by themselves establish cause.
  5. There is no evidence that COVID-19 vaccines cause cancer, according to the US National Cancer Institute.
  6. McCullough also promotes a supplement sold by a company with which he is associated.
FULL TEXT

Read the edited text by chapter

Transcript only
01

The pandemic response and public trust

Rogan and McCullough revisit their earlier conversation and describe their criticism of pandemic policy.

Joe Rogan and physician Peter McCullough begin by recalling their earlier COVID-19 conversation and the public criticism it drew. Both say they felt pandemic discussions were constrained and that authorities were slow to acknowledge errors.

Rogan recalls criticism from news organizations and the White House after his earlier pandemic interviews. McCullough asks how the label of misinformation became so prominent, and both question the way disagreement was handled.

McCullough argues that the language of misinformation became a tool for dismissing dissent. He describes his experience as a clinician during an emergency in which policy, public messaging and individual treatment decisions were closely intertwined.

The two compare the pandemic response to a war, discussing public fear, emergency measures and professional accountability. McCullough says he made the clinical decisions he believed were right and faced repercussions as a result.

McCullough says emergency laws and medical countermeasures changed the environment in which doctors made decisions. He uses the war analogy to describe clinicians as the people left to treat patients directly.

Rogan and McCullough endorse hydroxychloroquine and ivermectin as COVID-19 treatments. Their assertions should be weighed against the evidence: the [World Health Organization recommends against ivermectin for non-severe COVID-19 and limits its use in severe cases to clinical trials](https://www.who.int/news/item/10-11-2023-who-updates-guidelines-on-treatments-for-covid-19); it also recommends against hydroxychloroquine for COVID-19 treatment.

McCullough describes actions against people who marketed treatments and supplements, presenting them as evidence of an excessively restrictive response. The conversation does not establish the merits of the individual cases he mentions.

He proposes that public-health agencies and philanthropic organizations formed a coordinated system favoring vaccination. He and Rogan speculate about incentives and coordination; the discussion does not establish that the organizations deliberately suppressed effective treatments.

The guest describes public and private institutions involved in pandemic preparedness, then infers a shared agenda. Similar responses or professional connections alone do not demonstrate a coordinated plan.

The speakers also question vaccine-liability arrangements and call mRNA vaccines gene therapy. That characterization is misleading: the [WHO explains that mRNA vaccines do not alter a recipient’s DNA](https://www.who.int/news/item/17-05-2022-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness).

They discuss vaccine manufacturers, regulatory liability and the origins of SARS-CoV-2. McCullough favors a laboratory-accident hypothesis; the conversation itself does not resolve the origin of the virus.

McCullough recounts the career of a vaccine-company executive and links earlier coronavirus research with vaccine development. He treats those connections as suspicious, but does not establish a causal chain from them.

The host recalls visiting a high-containment laboratory for an earlier television program. McCullough then revisits investigations into the pandemic’s origins and alleges conflicts of interest and a cover-up.

They discuss international investigations and dispute conclusions about the virus’s origins. Scientific investigations have considered more than one hypothesis; certainty about a specific origin is not established by the conversation.

The discussion shifts to restrictions, including outdoor activities and masks. The speakers criticize particular policies and communications, though their broad assertions about transmission and mask effectiveness are not established by the anecdotes they offer.

Rogan describes restrictions on public activity and a dispute over a business’s masking policy. Both hosts treat these examples as illustrations of wider social division.

They discuss terms used in public debate and argue that scientific claims should be open to challenge. McCullough contrasts the uncertainty of clinical inference with the desire for clear answers during a new emergency.

McCullough says doctors often reason from incomplete evidence and update their judgments. That uncertainty makes transparent discussion important, but it does not make all proposed treatments equally well supported.

Both describe relationships strained by disagreements about vaccines. McCullough says he and his co-author began researching the history of immunization to understand why the topic had become so emotionally and politically charged.

02

Vaccines, history and pregnancy

The guest discusses vaccine history and safety; research provides important context for several claims.

McCullough traces part of that history to smallpox inoculation in colonial Boston and describes religious language used by its supporters. He argues that a strong faith in vaccination has persisted alongside public fear of infectious disease.

His historical account focuses on the religious and political language surrounding early inoculation. He contrasts that with his own emphasis on social and environmental measures used against infection.

Asked about early smallpox inoculation, he expresses uncertainty about its efficacy and emphasizes isolation, sanitation and nutrition. These measures matter, but they do not negate the measured contribution of vaccination: a [WHO-supported analysis estimated that immunization saved at least 154 million lives globally over 50 years](https://www.who.int/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years).

The speakers discuss how improvements in sanitation, hygiene, nutrition and medical care affect infectious-disease outcomes. Their discussion treats these measures and vaccination as competing explanations, although multiple interventions can contribute to falling mortality.

The guest discusses measles, nutrition and the difference between immunity after infection and vaccination. He acknowledges that measles vaccines reduce cases but argues that public reporting does not adequately communicate their limitations.

On measles, McCullough mentions vitamin A and treatment of complications. This does not establish that measles is harmless or that nutritional measures can substitute for prevention.

McCullough recounts his own antibody tests and a colleague’s illness after vaccination. Individual experiences cannot establish how often a vaccine prevents disease or whether it caused a particular outcome; population studies and surveillance are needed for those questions.

Rogan questions vaccination after prior COVID-19 infection. The speakers argue that infection-derived immunity was undervalued and discuss the relationship between immunity, mandates and public messaging.

Rogan describes conversations with friends and a journalist about vaccination after infection. His personal decisions and recollections do not resolve the different risks facing people of different ages and health conditions.

McCullough claims COVID-19 vaccination caused a large increase in pregnancy loss. That claim conflicts with published evidence: a [systematic review and meta-analysis found no evidence of an increased miscarriage risk after COVID-19 vaccination](https://pmc.ncbi.nlm.nih.gov/articles/PMC10152171/).

The guest cites an early pregnancy-monitoring paper and interprets incomplete follow-up as evidence of a very high miscarriage rate. Subsequent studies with appropriate comparison groups did not find the increase he alleges.

He recounts reports of pregnancy complications and argues that authorities did not have enough information when vaccines were introduced. A later [population-based cohort study likewise found no association with miscarriage](https://pubmed.ncbi.nlm.nih.gov/37946587/); an event following vaccination is not by itself proof of causation.

03

Treatment, testing and mandates

They discuss monoclonal antibodies, COVID-19 drugs and vaccination policies.

The conversation moves to monoclonal antibodies. McCullough says he wanted wider access for patients early in the pandemic, and Rogan recounts helping arrange care for people he knew.

McCullough describes a family in which two COVID-19 patients received different care and had different outcomes. A single comparison cannot show that one treatment caused either outcome because patients’ conditions and other care may differ.

Rogan recounts using his resources to send nurses to sick acquaintances. He says demand later exceeded his ability to find the antibody products he sought.

They question why some antibody products later became unavailable. The guest and host attribute decisions to a preference for vaccination, while acknowledging that changing virus variants were cited as a reason; their conversation does not establish the alleged motive.

The speakers point to pandemic-preparedness exercises and infer a pre-existing preference for mass vaccination. Planning exercises by themselves do not show that an outbreak was orchestrated or that beneficial care was intentionally withheld.

McCullough discusses several drugs used at different stages of the pandemic and criticizes hospital protocols, including use of remdesivir. He contrasts his own clinical experiences with official guidance.

McCullough says different treatments became available at different stages and discusses drug interactions and rebound. Whether an intervention is appropriate depends on the patient, the circulating virus and evidence available at the time.

He presents observational reports and personal cases as support for ivermectin. Larger, controlled evidence and clinical guidance are essential when assessing treatment effects; the WHO guidance cited above does not recommend routine use for COVID-19.

He cites a study and patient reports to argue that his treatment approach saved lives. Anecdotes and uncontrolled comparisons are vulnerable to differences between patients and cannot reliably establish that magnitude of benefit.

McCullough describes severe cases managed at home and advocates his own multi-drug approach. This account is not evidence that low oxygen levels can safely be managed without urgent medical care or that his treatment combination prevents death.

Rogan recalls media coverage of ivermectin and says some reports were inaccurate. McCullough discusses a legal dispute with the FDA over public messaging; neither establishes from that dispute that ivermectin is effective for COVID-19.

The speakers attribute resistance to their preferred treatments to censorship and professional pressure. McCullough describes disagreement in journals and retractions that he believes unfairly disadvantaged his work.

McCullough describes a lawyer’s account of patients whose families sought court orders for treatment. He recognizes that the account was not a randomized trial, but nevertheless draws a sweeping conclusion from it.

Rogan asks about vaccinating during a pandemic and viral variants. McCullough argues that a narrowly targeted vaccine can exert selection pressure; he and Rogan also criticize mandates and overly confident claims about preventing infection.

Using a model of the virus, McCullough explains his concern about spike mutations and immunity. The example is used to support his argument that infection and vaccination should be assessed separately.

They challenge assurances that vaccination would entirely stop transmission and criticize policies that followed. The distinction between reduced risk and complete prevention is important when communicating evidence.

They discuss statements made by public figures and the politicization of vaccine decisions. McCullough says medical uncertainty should have been communicated more openly, while Rogan recounts changing his mind about vaccination.

Rogan recounts nearly accepting a vaccine before hearing about illnesses among acquaintances. He says those events changed his attitude, though the timing of an illness alone cannot establish its cause.

Rogan describes illnesses among people he knew and his own COVID-19 experiences. These stories explain his concerns but cannot establish that a vaccine caused another person’s illness or that a particular supplement prevented infection.

The host describes his own exercise and supplement routine and attributes his health in part to it. His experience is not a controlled test of any supplement or a guide to treatment.

04

Cardiac events, cancer and evidence

McCullough draws conclusions from cases and promotes a supplement, while broader evidence differs on key questions.

McCullough discusses rare clotting problems associated with certain adenovirus-vector vaccines and argues more broadly that vaccine risks outweigh benefits. Risk differs by vaccine, age and individual circumstances; a generalized claim cannot substitute for that assessment.

McCullough mentions vaccine-induced clotting with low platelets after some adenovirus-vector vaccines. This is a real but rare serious adverse event; it should not be assumed to occur after every vaccine or every episode of clotting.

He argues that academic and editorial institutions are biased toward favorable vaccine findings. Rogan asks whether vaccine components or proteins might persist; McCullough describes research on one of his patients and proposes a mechanism.

The guest describes a laboratory finding in one patient and speculates about individual differences in clearance. He extends the discussion to health events years later, a causal connection the case alone cannot establish.

A single case cannot establish how common persistence is or whether it caused a particular health problem. The speakers’ further conclusions about widespread delayed effects require evidence beyond the case described in the interview.

Rogan asks about uptake of booster doses. McCullough describes his own estimate based on manufacturer sales and contrasts it with survey-based estimates, without providing enough information in the conversation to independently verify his calculation.

McCullough attributes cardiac emergencies in several named athletes to vaccination and speculates about their private treatment. Those claims are not established by the evidence presented in the conversation, and the article does not repeat individual medical diagnoses.

A recognized risk does exist: [CDC describes myocarditis after mRNA COVID-19 vaccination as an increased but rare risk](https://www.cdc.gov/acip/downloads/minutes/summary-2025-06-25-26-508.pdf). Establishing the cause of an individual cardiac event requires clinical evaluation rather than an inference from timing or public appearances.

The guest’s discussion of cardiac events blends established adverse-event concerns with unsupported claims about particular athletes. Publicly attributing an individual’s medical crisis to a vaccine without evidence risks misrepresenting the case.

The guest promotes a commercial supplement that he says removes spike protein and discusses his company’s role in selling it. The interview does not demonstrate that the product treats cardiac disease or replaces established medical care.

McCullough names ingredients in his company’s product and claims they can remove spike protein. The conversation does not provide clinical evidence that this supplement prevents strokes, treats myocarditis or eliminates the need for a prescribed device.

The speakers discuss vaccination records, professional athletes and people who chose not to be vaccinated. Rogan says he knows people who obtained false records; neither speaker presents systematic evidence for the scale of that practice.

They turn to cancer. McCullough proposes that COVID-19 vaccines promote cancer and speculates about named individuals. The [US National Cancer Institute says there is no evidence that COVID-19 vaccines cause cancer, make it recur or cause it to progress](https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer).

He points to reports of cancer among public figures as support for his theory. The existence of cancer after vaccination does not show the vaccine caused it; population data are needed to evaluate such a claim.

McCullough discusses laboratory mechanisms and raises questions about vaccine manufacturing and a genetic sequence associated with SV40. A proposed mechanism or a claimed finding in a sample is not, on its own, proof that a vaccine causes cancer in people.

The guest discusses historical contamination of early polio vaccine production and applies that concern to current manufacturing. He alleges inadequate regulatory investigation, but the interview does not independently establish the claim.

The speakers reflect on how widespread infection became and question whether restrictions were worthwhile. McCullough says the pandemic’s initial uncertainty led to responses he now considers excessive; Rogan notes how alarming early reports were.

They contrast early fears about a new virus with later knowledge that reinfections could occur. McCullough recounts how his own view changed as new variants emerged.

They discuss reinfection and immune responses after infection. Both draw on personal experience, but the degree and duration of protection vary, and an individual mild reinfection cannot establish another person’s risks.

Rogan asks about PCR tests and cycle thresholds. McCullough argues that false positives inflated case and death counts; the interview does not establish his broad numerical claims or show that the deaths he discusses were wrongly attributed.

McCullough argues that a positive PCR result could affect attribution on a death certificate. He then makes broader claims about false positives and financial incentives without demonstrating them in the discussion.

The guest extends his criticism to measles testing and hospital reimbursement. He suspects political and financial incentives affected reporting, but the discussion supplies no independent evidence for specific allegations against officials or medical examiners.

The guest questions hospital performance and asks for comparisons of mortality and treatment practices. The speakers frame this as a way to draw lessons for future public-health emergencies.

McCullough advocates comparing hospital outcomes and learning from pandemic care. He says his company offers medical products and pharmacies, and he presents that business as part of his preferred response to a future emergency.

05

Career consequences and what comes next

The conversation ends with the guest’s professional experience and views on public spending.

McCullough promotes his company’s pharmacy and preparedness offerings. His commercial relationship with the company is relevant to assessing those product claims.

Asked about the personal cost of speaking out, he says he lost academic roles, editorial positions, grants and other opportunities. He describes the experience as painful but says he would make the same decisions again.

He says professional costs included lost roles and strained relationships. The account describes his experience; it does not by itself establish the reasons for every institutional decision he mentions.

He says he has built a new practice and business and hopes to return to academic discussion. He also predicts long-term harms from the pandemic and vaccination, extending interpretations that have not been established by the cases he cites.

The guest speculates about trends in mortality and fertility. Population trends have multiple possible explanations, and the named anecdotes offered in the interview do not establish that vaccination caused them.

The conversation ends with public spending and government finances. McCullough argues that emergency spending expanded rapidly and warns about future fiscal strain; Rogan closes by thanking him for appearing.

More from this channel

2:22:43EN
PowerfulJRE· Nov 17, 2026Podcast · 2 speakersTommy McMillen on Fighting, Setbacks and Finding DisciplineGuest Tommy McMillen · Host Joe RoganThe UFC featherweight traces his path from Montana to Arizona and reflects on the risks behind his rapid rise.Combat Sports
2:21:10EN
PowerfulJRE· Nov 12, 2026Podcast · 2 speakersKenneth Lacovara on Dinosaur Evidence—and What Fossils Cannot Tell UsGuest Kenneth Lacovara · Host Joe RoganA paleontologist explains how fossils are found, why displays use replicas, and where reconstructions and extinction theories remain uncertain.EvolutionScience CommunicationHistory
2:55:43EN
PowerfulJRE· Nov 11, 2026Podcast · 3 speakersPaddy Pimblett on fighting, weight cuts and the lightweight divisionGuest Paddy Pimblett · Host Joe RoganPimblett explains his Saint Denis finish, his difficult recovery from ankle surgery, and why he refuses to fight teammates.Combat SportsMartial ArtsJiu Jitsu+1
2:10:00EN
PowerfulJRE· Nov 10, 2026Podcast · 2 speakersGary Sinise on supporting veterans and remembering his son MacGuest Gary Sinise · Host Joe RoganThe actor traces his foundation work, his path into theater and the family story behind Graceful Warrior.Mental HealthPersonal Growth
2:18:31EN
PowerfulJRE· Nov 6, 2026Podcast · 2 speakersCalley Means on Leaving the White House and Lobbying in Health PolicyGuest Calley Means · Host Joe RoganThe former adviser describes internal health-policy disputes and calls for campaign-finance reform; the interview contains contested medical and political claims.Public Health
2:16:39EN
PowerfulJRE· Nov 5, 2026Podcast · 2 speakersGregory Forth on Flores Fossils and Reports of Humanlike BeingsGuest Gregory Forth · Host Joe RoganThe anthropologist discusses fieldwork, local traditions and a disputed hypothesis about a surviving hominin.EvolutionHistoryScience Communication